Le Lézard
Classified in: Health, Covid-19 virus
Subject: NPT

'Help India Defeat COVID-19' Campaign Raises Over $7 Million; More than 100,000 Pitch In


HOUSTON, May 6, 2021 /PRNewswire/ -- Sewa International has reached the 101,000-donor mark and raised over $7 million from its 'Help India Defeat COVID-19' Facebook campaign within 10 days of launching the campaign, indicating massive support from Americans to help India in its hour of need.

Started with a modest goal of $500,000 on April 25 as India started seeing a drastic increase in the number of cases reported daily, Sewa's Facebook campaign has grown in strength. Based on rapidly changing needs on the ground, Sewa moved the campaign's fundraising target thrice, to $1 million, $5 million, and then to $10 million dollars, responding both to the felt need for medical equipment in India, and the emotional commitment of donors to alleviating the suffering of millions.  

Sewa is running multiple campaigns to raise money for this cause on different social media platforms and also on its website. Sewa is approaching corporates, community organizations and foundations and In many cases these institutions are reaching out to Sewa on their own and offering help.

"It is heartening to see Americans generously donating to help India face the challenge posed by the COVID-19 second wave. I am deeply moved by the love and warmth thousands of Americans have shown to India through their donations. People are urging others to donate showing Americans are standing solidly with India at this moment," Arun Kankani, President, Sewa International said.

Oxygen Concentrators Reach India

Sewa International representatives received 1,148 oxygen concentrators on May 4, 2021, and 318 of them on May 3, 2021. Sewa International's partner organization, Sewa United Kingdom has also sent another 50 oxygen concentrators.  Sewa International volunteers transported all of them to their warehouse in Delhi for distribution to cities and hospitals across the country.

The Sewa India team has also received 139 oxygen concentrators from the United Arab Emirates. "Sewa teams from many different countries are working with their local communities to raise funds to help India in the current COVID-19 crisis," Arun Kankani said.  

"We are receiving a lot of requests for ventilators, and right now, 256 co-ventilators are in transit to Atlanta, GA. We are placing orders for 150 ventilators with Philips in India, and Philips is donating another fifty," Srikanth Gundavarapu, who is leading the Sewa Procurement Team, said.

"Sewa has procured 1,688 oxygen concentrators in the US in addition to the 2,584 we have already sent to India. Our procurement team is acting fast to obtain more of these machines. We are seeing an increasing demand for many lifesaving equipment, and we are placing orders for 160 Bi PAP machines soon," Srikanth Gundavarapu said.

About Sewa International

Sewa International (www.sewausa.org) is a 501 (c)(3) Hindu faith-based charitable nonprofit that works in the areas of disaster recovery, education, and development. Sewa has 43 Chapters across the USA and serves regardless of race, color, religion, sex, age, disability, or national origin.

CONTACT:
Vidyasagar Tontalapur ? 1 - 720-526-9939
Viswanath Koppaka ? 1- 404-304-0563
Email: [email protected]
Web: http://www.sewausa.org

SOURCE Sewa International


These press releases may also interest you

at 10:31
Recently, GenScript Biotech Corporation (HK.1548), a world leader in technologies and services for life science R&D and manufacture, released its 2023 Environmental, Social, and Governance (ESG) report. This report showcases the company's dedicated...

at 10:30
Vaccines Market in terms of revenue was estimated to be worth $78.0 billion in 2024 and is poised to reach $94.9 billion by 2029, growing at a CAGR of 4.0% from 2024 to 2029 according to a new report by MarketsandMarketstm. Similarly, the vaccines...

at 10:25
Aulos Bioscience, an immuno-oncology company working to revolutionize cancer care through the development of potentially best-in-class IL-2 therapeutics, today announced that updated Phase 1/2 data for AU-007 will be presented at the American Society...

at 10:20
A monument park and website honoring medical frontline and essential workers worldwide who risked their lives during the COVID-19 pandemic will break ground this summer in Chicago, Illinois. The COVID-19 Monument of Honor, Remembrance, and Resilience...

at 10:20
Precigen, Inc. , a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the lives of patients, today announced clinical data from the pivotal Phase 2 study of PRGN-2012 AdenoVerse immunotherapy...

at 10:20
The two poster presentations will report -first combination data from the Phase 1/2a study with BI-1808 in combination with MSD's anti-PD-1 therapy, KEYTRUDA® (pembrolizumab), as well as an update on monotherapy armcombination data from the...



News published on and distributed by: